POLG and myelodysplastic syndrome: Building on previous findings we wanted to further explore nucleoside supplementation in MDS using patient derived cells with mutations in POLG, DGUOK and TWNK. To our knowledge the benefits of nucleoside supplementation have never been investigated in TWNK deficiency.